Current issues and considerations regarding Trichomoniasis and human immunodeficiency virus in African-Americans

Clinical Microbiology Reviews

Volumn 22, Issue 1, 2009, Pages 37-45

  Shafir, Shira C ^a   Sorvillo, Frank J ^a,b   Smith, Lisa ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; VIRUS TRANSMISSION; ANIMAL; DISEASE TRANSMISSION; ISOLATION AND PURIFICATION; PARASITOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

AFRICAN AMERICANS; ANIMALS; HIV INFECTIONS; HUMANS; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 59649095091     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00002-08     Document Type: Review

References (109)

1. Anonymous. 1995. An overview of selected curable sexually transmitted diseases, p. 2-27. Global program on AIDS. World Health Organization, Geneva, Switzerland.
2. Aral, S., and K. K. Holmes. 1989. Epidemiology of sexual behavior and sexually transmitted diseases, p. 19-36. In K. K. Holmes, P.-A. Mardh. P. F. Sparling, P. J. Wiesner, W. Cates, Jr.. S. M. Lemon, and W. E. Stamm (ed.), Sexually transmitted diseases, 2nd ed. McGraw-Hill Inc., New York, NY.
3. Aral, S. O., W. D. Mosher, and W. Cates, Jr. 1992. Vaginal douching among women of reproductive age in the United States: 1988. Am. J. Public Health 82:210-214.
4. Barbone, F., H. Austin, W. C. Louv, and W. J. Alexander. 1990. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am. J. Obstet. Gynecol. 163: 510-514.
5. Beal, C., R. Goldsmith, M. Kotby, M. Sherif, A. el-Tagi, A. Farid, S. Zakaria, and J. Eapen. 1992. The plastic envelope method, a simplified technique for culture diagnosis of trichomoniasis. J. Clin. Microbiol. 30: 2265-2268.
6. Bell, T. A., J. A. Farrow, W. E. Stamm, C. W, Critchlow, and K. K. Holmes. 1985. Sexually transmitted diseases in females in a juvenile detention center. Sex. Transm. Dis. 12:140-144.
7. Bersoff-Matcha, S. J., M. M. Horgan, V. J. Fraser, L. M. Mundy, and B. P. Stoner. 1998. Sexually transmitted disease acquisition among women infected with human immunodeficiency vims type 1. J. Infect. Dis. 178:1174-1177.
8. Borchardt, K. A., S. al-Haraci, and N. Maida. 1995. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin. Med. 71:405-406.
9. Briselden, A. M., and S. L. Hillier. 1994. Evaluation of Affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 32:148-152.
10. Bunnell, R. E., L. Dahlberg, R. Rolfs, R. Ransom, K. Gershman, C. Farshy, W. J. Newhall, S. Schmid, K. Stone, and M. St. Louis. 1999. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J, Infect. Dis. 180:1624-1631.
11. Campbell, L., V. Woods, T. Lloyd, S. Elsayed, and D. L. Church. 2008. Evaluation of the OSOM Trichomonas rapid test versus wet prep examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J. Clin. Microbiol. 46:3467-3469.
12. Cates, W., Jr., et al. 1999. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis. 26: S2-S7.
13. Chesson, H. W., J. M. Blandford, and S. D. Pinkerton. 2004. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex. Transm. Dis. 31:547-551.
14. Cotch, M. F., J. G. Pastorek II, R. P. Nugent, S. L. Hillier, R. S. Gibbs, D. H. Martin, D. A. Eschenbach, R. Edelman, J. C. Carey, J. A. Regan, M. A. Krohn, M. A. Klebanoff, A. V. Rao, G. G. Rhoads, et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360.
15. Cotch, M. F., J. G. Pastorek II, R. P. Nugent, D. E. Yerg, D. H. Martin, D. A. Eschenbach, et al. 1991. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstet. Gynecol. 78:1087-1092.
16. Crosby, R., R. J. DiClemente, G. M. Wingood, K. Harrington, S. L. Davies, E. W. Hook III, and M. K. Oh. 2002. Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex. Transm. Infect. 78:360-364.
17. Crosby, R. A., R. J. Diclemente, G. M. Wingood, L. F. Salazar, D. Lang, E. Rose, and J. McDermott-Sales. 2008. Co-occurrence of intoxication during sex and sexually transmissible infections among young African American women: does partner intoxication matter? Sex. Health 5:285-289.
18. Cu-Uvin, S., J. W. Hogan, D. Warren, R. S. Klein, J. Peipert, P. Schuman, S. Holmberg, J. Anderson, E. Schoenbaum, D. Vlahov, K. H. Mayer, et al. 1999. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. Clin. Infect. Dis. 29:1145-1150.
19. Cu-Uvin, S., H. Ko, D. J. Jamieson, J. W. Hogan, P. Schuman, J. Anderson, and R. S. Klein. 2002. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin. Infect. Dis. 34:1406-1411.
20. DeHovitz, J. A., P. Kelly, J. Feldman, M. F. Sierra, L. Clarke, J. Bromberg, J. Y. Wan, S. H. Vermund, and S. Landesman. 1994. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am. J. Epidemiol. 140:1125-1134.
21. Diclemente, R. J., G. M. Wingood, R. A. Crosby, E. Rose, D. Lang, A. Pillay, J. Papp, and C. Faushy. 2004. A descriptive analysis of STD prevalence among urban pregnant African-American teens: data from a pilot study. J. Adolesc. Health 34:376-383.
22. Draper, D., W. Donohoe, L. Mortimer, and R. P. Heine. 1998. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J. Infect. Dis. 178:815-819.
23. Dunne, R. L., L. A. Dunn, P. Upcroft, P. J. O'Donoghue, and J. A. Upcroft. 2003. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell. Res. 13:239-249.
24. Fleisher, J. M., R. T. Senie, H. Minkoff, and J. Jaccard. 1994. Condom use relative to knowledge of sexually transmitted disease prevention, method of birth control, and past or present infection. J. Commun. Health 19:395-407.
25. Fortenberry, J. D., E. J. Brizendine, B. P. Katz, K. K. Wools, M. J. Blythe, and D. P. Orr. 1999. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis. Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex. Transm. Dis. 26:26-32.
26. Fouts, A. C., and S. J. Kraus. 1980. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 141:137-143.
27. Garber, G. E. 2005. The laboratory diagnosis of Trichomonas vaginalis. Can. J. Infect. Dis. Med. Microbiol." 16:35-38.
28. Garber, G. E., L. Sibau, R. Ma, E. M. Proctor, C. E. Shaw, and W. R. Bowie. 1987. Cell culture compared with broth for detection of Trichomonas vaginalis. J. Clin. Microbiol. 25:1275-1279.
29. Ghys, P. D., M. O. Diallo, V. Ettiegne-Traore, K. M. Yeboue, E. Gnaore, F. Lorougnon, K. Kale, E. Van Dyck, K. Brettegaard, Y. M. Hoyi, et al. 1995. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J. Infect. Dis. 172:1371-1374.
30. Grady, W. R., and K. Tanfer. 1994. Condom breakage and slippage among men in the United States. Fam. Plann. Perspect. 26:107-112.
31. Grosskurth, H., F. Mosha, J. Todd, E. Mwijarubi, A. Klokke, K. Senkoro, P. Mayaud, J. Changalucha, A. Nicoll, G. ka-Gina, et al. 1995. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346:530-536.
32. Guenthner, P. C., W. E. Secor, and C. S. Dezzutti. 2005. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect. Immun. 73:4155-4160.
33. Hardy, P. H., J. B. Hardy, E. E. Nell, D. A. Graham, M. R. Spence, and R. C. Rosenbaum. 1984. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 2:333-337.
34. Harrington, K. F., R. J. DiClemente, G. M. Wingood, R. A. Crosby, S. Person, M. K. Oh, and E. W. Hook III. 2001. Validity of self-reported sexually transmitted diseases among African American female adolescents participating in an H1V/STD prevention intervention trial. Sex. Transm. Dis. 28:468-471.
35. Hobbs, M. M., P. Kazembe, A. W. Reed, W. C. Miller, E. Nkata, D. Zimba, C. C. Daly, H. Chakraborty, M. S. Cohen, and I. Hoffman. 1999. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 26:381-387.
36. Ingersoll, J., T. Bythwood, D. Abdul-Ali, G. M. Wingood, R. J. Diclemente, and A. M. Caliendo. 2008. Stability of Trichomonas vaginalis DNA in urine specimens. J. Clin. Microbiol. 46:1628-1630.
37. Ipsen, J., and P. Feigl. 1970. A biomathematical model for prevalence of Trichomonas vaginalis. Am. J. Epidemiol. 91:175-184.
38. Jackson, D. J., J. P. Rakwar, J. J. Bwayo, J. K. Kreiss, and S. Moses. 1997. Urethral Trichomonas vaginalis infection and HIV-1 transmission. Lancet 350:1076.
39. Johnston, V. J., and D. C. Mabey. 2008. Global epidemiology and control of Trichomonas vaginalis. Curr. Opin. Infect. Dis. 21:56-64.
40. Joyner, J. L., J. M. Douglas, Jr., S. Ragsdale, M. Foster, and F. N. Judson. 2000. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex. Transm. Dis. 27:236-240.
41. Kissinger, P., N. Schmidt, H. Mohammed, J. S. Leichliter, T. L. Gift, B. Meadors, C. Sanders, and T. A. Farley. 2006. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex. Transm. Dis. 33:445-450.
42. Kissinger, P., W. E. Secor, J. S. Leichliter, R. A. Clark, N. Schmidt, E. Curtin, and D. H. Martin. 2008. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin. Infect. Dis. 46:994-999.
43. Kiviat, N. B., J. A. Paavonen, J. Brockway, C. W. Critchlow, R. C. Brunham, C. E. Stevens, W. E. Stamm, C. C. Kuo, T. DeRouen, and K. K. Holmes. 1985. Cytologic manifestations of cervical and vaginal infections. 1. Epithelial and inflammatory cellular changes. JAMA 253:989-996.
44. Kreiss, J., D. M. Willerford, M. Hensel, W. Emonyi, F. Plummer, J. Ndinya-Achola, P. L. Roberts, J. Hoskyn, S. Hillier, and N. Kiviat. 1994. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J. Infect. Dis. 170:1597-1601.
45. Krieger, J. N., C. Jenny, M. Verdon, N. Siegel, R. Springwater, C. W. Critchlow, and K. K. Holmes. 1993. Clinical manifestations of trichomoniasis in men. Ann. Intern. Med. 118:844-849.
46. Krieger, J. N., M. Verdon, N. Siegel, C. Critchlow, and K. K. Holmes. 1992. Risk assessment and laboratory diagnosis of trichomoniasis in men. J. Infect. Dis. 166:1362-1366.
47. Kurth, A., W. L. Whittington, M. R. Golden, K. K. Thomas, K. K. Holmes, and J. R. Schwebke. 2004. Performance of a new, rapid assay for detection of Trichomonas vaginalis. J. Clin. Microbiol. 42:2940-2943.
48. Laga, M., A. Manoka, M. Kivuvu, B. Malele, M. Tuliza, N. Nzila, J. Goe-man, F. Behets, V. Batter, M. Alary, et al. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95-102.
49. Lawing, L. F., S. R. Hedges, and J. R. Schwebke. 2000. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J. Clin. Microbiol. 38:3585-3588.
50. Levi, M. H., J. Torres, C. Pina, and R. S. Klein. 1997. Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J. Clin. Microbiol. 35:3308-3310.
51. Levine, W. C., V. Pope, A. Bhoomkar, P. Tambe, J, S. Lewis, A, A. Zaidi, C. E. Farshy, S. Mitchell, and D. F. Talkington. 1998. Increase in endo-cervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177:167-174.
52. Lichtenstein, B., and J. R. Schwebke. 2005. Partner notification methods for African American men being treated for trichomoniasis: a consideration of main men. second hitters, and third players. Med. Anthropol. Q. 19:383-401.
53. Lossick, J. G. 1980. Single-dose metronidazole treatment for vaginal trichomoniasis. Obstet. Gynecol. 56:508-510.
54. Lossick, J. G., M. Muller, and T. E. Gorrell. 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153:948-955.
55. Madico, G., T. C. Quinn, A. Rompalo, K. T. McKee, Jr., and C. A. Gaydos. 1998. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J. Clin. Microbiol. 36:3205-3210.
56. Magnus, M., R. Clark, L. Myers, T. Farley, and P. J. Kissinger. 2003. Trichomonas vaginalis among HIV-infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex. Transm. Dis. 30:839-843.
57. Mayta, H, R. H, Gilman, M. M. Calderon, A. Gottlieb, G, Soto, I. Tuero, S. Sanchez, and A. Vivar. 2000. 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J. Clin. Microbiol. 38:2683-2687.
58. McClelland, R. S., B. A. Richardson, W. M. Hassan, V. Chohan, L. Lavreys, K. Mandaliya, J. Kiarie, W. Jaoko, J. O. Ndinya-Achola, J. M. Baeten, A. E. Kurth, and K. K. Holmes. 2008. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J. Infect. Dis. 197:1361-1368.
59. McClelland, R. S., L, Sangare, W. M. Hassan, L. Lavreys, K. Mandaliya, J. Kiarie, J. Ndinya-Achola, W. Jaoko, and J. M. Baeten. 2007. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J. Infect. Dis. 195:698-702.
60. McCormack, W. M., J. R. Evrard, C. F. Laughlin, B. Rosner, S. Alpert, V. A. Crockett, D. McComb, and S. H. Zinner. 1981. Sexually transmitted conditions among women college students. Am. J. Obstet. Gynecol. 139:130-133.
61. Miller, G. A., J. D. Klausner, T. J. Coates, R. Meza, C. A. Gaydos, J. Hardick, S. Leon, and C. F. Caceres. 2003. Assessment of a rapid antigen detection system for Trichomonas vaginalis infection. Clin. Diagn. Lab. Immunol. 10:1157-1158.
62. Miller, J. M., and D. C. Chambers. 1989. Infection with Trichomonas vaginalis in a black population. J. Natl. Med. Assoc. 81:701-702.
63. Miller, M., Y. Liao, A. M. Gomez, C. A. Gaydos, and D. D'Mellow. 2008. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs. J. Infect. Dis. 197:503-509.
64. Miller, W. C, H. Swygard, M. M. Hobbs, C. A. Ford, M. S. Handcock, M. Morris, J. L. Schmitz, M. S. Cohen, K. M. Harris, and J. R. Udry. 2005. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis. 32:593-598.
65. Moodley, P., C. Connolly, and A. W. Sturm, 2002. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J. Infect. Dis. 185:69-73.
66. Moodley, P., D. Wilkinson, C. Connolly, J. Moodley, and A. W. Sturm. 2002. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis. 34:519-522.
67. Munson, E., M. Napierala, R. Olson, T. Endes, T. Block, J. E. Hryciuk, and R. F. Schell. 2008. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46:3368-3374.
68. Niccolai, L. M., J. J. Kopicko, A. Kassie, H. Petros, R. A. Clark, and P. Kissinger. 2000. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex. Transm. Dis. 27:284-288.
69. Osborne, N. G., L. Grubin, and L. Pratson. 1982. Vaginitis in sexually active women: relationship to nine sexually transmitted organisms. Am. J. Obstet. Gynecol. 142:962-967.
70. Pabst, K. M., C. A. Rekhart, C. R. Knud-Hansen, J. N. Wasserheit, T. C. Quinn, K. Shah, G. Dallabetta, and E. W. Hook III. 1992. Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit. Sex. Transm. Dis. 19:88-91.
71. Patel, S. R., W. Wiese, S. C. Patel, C. Ohl, J. C. Byrd, and C. A. Estrada. 2000. Systematic review of diagnostic tests for vaginal trichomoniasis. Infect. Dis. Obstet. Gynecol. 8:248-257.
72. Peterman, T. A., L. H. Tian, C. A. Metcalf, C. L. Satterwhite, C. K. Malotte, N. DeAugustine, S. M. Paul, H. Cross, C. A. Rietmeijer, and J. M. Douglas, Jr. 2006. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann. Intern. Med. 145:564-572.
73. Pillay, A., J. Lewis, and R. C. Ballard. 2004. Evaluation of Xenostrip-Tv, a rapid diagnostic test for Trichomonas vaginalis infection. J. Clin. Microbiol. 42:3853-3856.
74. Plitt, S. S., R. S. Garfein, C. A. Gaydos, S. A. Strathdee, S. G. Sherman, and T. E. Taha. 2005. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex. Transm. Dis. 32:446-453.
75. Price, M. A., W. C. Miller, S. C. Kaydos-Daniels, I. F. Hoffman, D. Chi-longozi, F. E. Martinson, D. Namakhwa, J. Malanda, and M. Cohen. 2004. Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi. J. Infect. Dis. 190:1448-1455.
76. Price, M. A., D. Zimba, I. F. Hoffman, S. C. Kaydos-Daniels, W. C. Miller, F. Martinson, D. Chilongozi, E. Kip, E. Msowoya, M. M. Hobbs, P. N. Kazembe, and M. S. Cohen. 2003. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial Sex. Transm. Dis. 30:516-522.
77. Ris, H. W., and R. W. Dodge. 1973. Trichomonas and yeast vaginitis in institutionalized adolescent girls. WMJ 72:150.
78. Salazar, L. F., R. A. Crosby, R. J. Diclemente, G. M. Wingood, E. Rose, J. M. Sales, and A. M. Caliendo. 2007. Personal, relational, and peer-level risk factors for laboratory confirmed STD prevalence among low-income African American adolescent females. Sex. Transm. Dis. 34:761-766.
79. Sardana, S., P. Sodhani, S. S. Agarwal, A. Sehgal, M. Roy, V. Singh, P. Bhatnagar, and N. S. Murthy. 1994. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol. 38:693-697.
80. Reference deleted.
81. Saxena, S. B, and R. R. Jenkins. 1991. Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases. Sex. Transm. Dis. 18:138-142.
82. Scholes, D., A, Stergachis, L. E. Ichikawa, F. E. Heidrich, K. K. Holmes, and W. E. Stamm. 1998. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet. Gynecol. 91:993-997.
83. Schwebke, J. R., and F. J. Barrientes. 2006. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimi-crob. Agents Chemother. 50:4209-4210.
84. Schwebke, J. R., and D. Burgess. 2004. Trichomoniasis. Clin. Microbiol. Rev. 17:794-803.
85. Schwebke, J. R., and E. W. Hook III. 2003. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J. Infect. Dis. 188:465-468.
86. Schwebke, J. R., S. C. Morgan, and G. B. Pinson. 1997. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J. Clin. Microbiol. 35:1618-1619.
87. Schwebke, J. R., M. F. Venglarik, and S. C. Morgan. 1999. Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis. J. Clin. Microbiol. 37:2369-2370.
88. Sena, A. C, W. C. Miller, M. M. Hobbs, J. R. Schwebke, P. A. Leone, H. Swygard, J. Atashili, and M. S. Cohen. 2007. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin. Infect. Dis. 44:13-22.
89. Sexton, J., G. Garnett, and J. A. Rottingen. 2005. Metaanalysis and metar-egression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex. Transm. Dis. 32: 351-357.
90. Shafer, M. A., R. L. Sweet, M. J. Ohm-Smith, J. Shalwitz, A. Beck, and J. Schachter. 1985. Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J. Pediatr. 107:974-981.
91. Shafir, S. C, and F. J. Sorvillo. 2006. Viability of Trichomonas vaginalis in urine: epidemiologic and clinical implications. J. Clin. Microbiol. 44:3787-3789.
92. Shuter, J., D. Bell, D. Graham, K. A. Holbrook, and E. Y. Bellin. 1998. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex. Transm. Dis. 25:303-307.
93. Sorvillo, F., A. Kovacs, P. Kerndt, A. Stek, L. Muderspach, and L. Sanchez-Keeland. 1998. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles Countv. California: implications for HIV prevention. Am. J. Trop. Med. Hyg. 58:495-500.
94. Stewart, D. L., B. R. DeForge, P. Hartmann, M. Kaminski, and E. Pecuko-nis. 1991. Attitudes toward condom use and AIDS among patients from an urban family practice center. J. Natl. Med. Assoc. 83:772-776.
95. Sutton, M., M. Sternberg, E. H. Koumans, G. McQuillan, S. Berman, and L. Markowitz. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States. 2001-2004. Clin. Infect. Dis. 45:1319-1326.
96. Swygard, H., W. C. Miller, S. C. Kaydos-Daniels, M. S. Cohen, P. A. Leone, M. M. Hobbs, and A. C. Sena. 2004. Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex. Transm. Dis. 31:659-664.
97. ter Meulen, J., H. N. Mgaya, J. Chang-Claude, J. Luande, H, Mtiro, M. Mhina, P. Kashaija, and M. Pawlita. 1992. Risk factors for HIV infection in gynaecological inpatients in Dar es Salaam. Tanzania, 1988-1990. East Afr. Med. J. 69:688-692.
98. Van Der Pol, B., C. Kwok, B. Pierre-Louis, A. Rinaldi, R. A. Salata, P. L. Chen, J. van de Wijgert, F. Mmiro, R. Mugerwa, T. Chipato, and C. S. Morrison. 2008. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J. Infect. Dis. 197:548-554.
99. Van Der Pol, B., J. A. Williams, D. P. Orr, B. E. Batteiger, and J. D. Fortenberry. 2005. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J. Infect. Dis. 192:2039-2044.
100. van Der Schee, C, A. van Belkum, L. Zwijgers, E. van Der Brugge, E. L. O'Neill, A. Luijendijk, T. van Rijsoort-Vos, W. I. van Der Meijden, H. Verbrugh, and H. J. Sluiters. 1999. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J. Clin. Microbiol. 37:4127-4130.
101. Wang, C. C, R. S. McClelland, M. Reilly, J. Overbaugh, S. R. Emery, K. Mandaliya, B. Chohan, J. Ndinya-Achola, J. Bwayo, and J. K. Kreiss. 2001. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J. Infect. Dis. 183:1017-1022.
102. Wasserheit, J. N. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
103. Watson-Jones, D., K. Mugeye, P. Mayaud, L. Ndeki, J. Todd, F. Mosha, B. West, B. Cleophas-Frisch, H. Grosskurth, M. Laga, R. Hayes, D. Mabey, and A. Buve. 2000. High prevalence of trichomoniasis in rural men in Mwanza. Tanzania: results from a population based study. Sex. Transm. Infect. 76:355-362.
104. Wendel, K. A., and K. A. Workowski. 2007. Trichomoniasis: challenges to appropriate management. Clin. Infect. Dis. 44(Suppl 3):S123-S129.
105. Wiese, W., S. R. Patel, S. C. Patel, C. A. Ohl, and C. A. Estrada. 2000. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am. J. Med. 108:301-308.
106. Wilkinson, D., S. S. A. Karim, A. Harrison, M. Lurie, M. Colvin, C. Connolly, and A. W. Sturm. 1999. Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic. Bull. W. H. O. 77:22-28.
107. Wilson, T. E., H. Minkoff, J. DeHovitz, J. Feldman, and S. Landesman. 1998. The relationship of cocaine use and human immunodeficiency vims serostatus to incident sexually transmitted diseases among women. Sex. Transm. Dis. 25:70-75.
108. Wilson, T. E., H. Minkoff, S. McCalla, C. Petterkin, and J. Jaccard. 1996. The relationship between pregnancy and sexual risk taking. Am. J. Obstet. Gynecol. 174:1033-1036.
109. Wolner-Hanssen, P., J. N. Krieger, C. E. Stevens, N. B. Kiviat, L. Koutsky, C. Critchlow, T. DeRouen, S. Hillier, and K. K. Holmes. 1989. Clinical manifestations of vaginal trichomoniasis. JAMA 261:571-576.